Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
SPDR S&P Biotech ETF Price
SPDR S&P Biotech ETF price

SPDR S&P Biotech ETF tokenized stock pricerXBI

Bitget rToken: 1:1 pegged to real U.S. stocks
Listed
Buy rXBI
$155.25USD
-0.24%1D
The price of SPDR S&P Biotech ETF (rXBI) in United States Dollar is $155.25 USD.
Price chart
SPDR S&P Biotech ETF/USD live price chart (rXBI/USD)
Last updated as of 2026-08-07 16:35:21(UTC+0)
All rToken price data comes from Bitget's spot stock trading market as well as Nasdaq or the NYSE.

Live SPDR S&P Biotech ETF price today in USD

The live SPDR S&P Biotech ETF price today is $155.25 USD, with a current market cap of --. The SPDR S&P Biotech ETF price is down by 0.24% in the last 24 hours, and the 24-hour trading volume is $0.00. The rXBI/USD (SPDR S&P Biotech ETF to USD) conversion rate is updated in real time.
How much is 1 SPDR S&P Biotech ETF worth in United States Dollar?
As of now, the SPDR S&P Biotech ETF (rXBI) price in United States Dollar is valued at $155.25 USD. You can buy 1rXBI for $155.25 now, you can buy 0.06441 rXBI for $10 now. In the last 24 hours, the highest rXBI to USD price is $155.76 USD, and the lowest rXBI to USD price is $154.99 USD.

Do you think the price of SPDR S&P Biotech ETF will rise or fall today?

Total votes:
Rise
0
Fall
0
Voting data updates every 24 hours. It reflects community predictions on SPDR S&P Biotech ETF's price trend and should not be considered investment advice.

In-depth analysis of SPDR S&P Biotech ETF's market trends today

SPDR S&P Biotech ETF market summary

The current price of SPDR S&P Biotech ETF (rXBI) is $155.25, with a 24-hour change of -0.24%. The current market capitalization is approximately --, and the 24-hour trading volume is $0.00.

SPDR S&P Biotech ETF Key Takeaways

Based on real-time chart analysis, the current technical structure of the SPDR S&P Biotech ETF (XBI) shows a market key support level at $88.50 and a major resistance level at $98.20. If the XBI price moves out of this range, it could trigger a new trend phase. Overall, the market is currently in a Consolidation phase, with price fluctuations primarily concentrated within these key technical boundaries.

Technical Indicators

RSI: Currently at 52, showing market momentum is Neutral.
MACD: The signal is Neutral-Bullish with the histogram showing minor positive ticks near the zero line.
MA: Mixed Structure (The price is currently hovering slightly above the 50-day moving average, suggesting a cautious mid-term bullish bias, while remaining below the 200-day average, indicating long-term overhead pressure).

Market Drivers

The current XBI price and market sentiment are primarily influenced by the following factors:
Interest Rate Expectations: As a high-growth, capital-intensive sector, biotech remains highly sensitive to treasury yields and macroeconomic shifts.
M&A Activity: Recent acquisition rumors and licensing deals within the mid-cap biotech space are providing localized support to the underlying index components.
Clinical Data Cycles: Investor sentiment is currently driven by a heavy schedule of Phase 2 and Phase 3 data readouts, which dictate the volatility of the ETF's equal-weighted holdings.

Trading Signals

Potential Buy Zone

• If the XBI price approaches the $88.50 - $90.00 level and displays a bounce signal, it may form a short-term buying opportunity.
• If the XBI price breaks above $98.20 accompanied by an increase in volume, it may confirm a new upward trend.

Risk Scenario

• If the XBI price falls below $88.50, the market may enter a short-term adjustment phase, potentially retesting deeper support levels.

Buy Strategy

Conservative Investors

• Wait for the XBI price to pull back to the $88.50 support level to buy in batches.
• Or wait for the price to effectively break and hold above the $98.20 resistance before following the trend.

Trend Investors

• If the price breaks the $98.20 resistance, a new uptrend may form.
• The next stage target price could be around $104.50.

Long-term Investors

• As long as the market maintains above the $85.00 structural floor, the medium-to-long-term trend is likely to remain in an upward-sloping structure.

Trends Summary

Market Insights

From a short-term perspective, XBI has exhibited a Range-bound price structure over the past 7 days, with overall market sentiment being Cautiously Optimistic. Mid-term analysis shows the price currently oscillating between the $88.50 support and $98.20 resistance zones.

Market Outlook

If the XBI price breaks $98.20, the next target price could be $104.50.
If the XBI price falls below $88.50, the next target price could be $82.10.

Market Consensus

Based on multiple analyst perspectives, the consensus is: although XBI may experience volatility or sideways movement in the short term, as long as the price stays above the key support level of $88.50, the medium-term trend is expected to remain Positive.

Now that you understand the market, it's time to start trading. SPDR S&P Biotech ETF (rXBI) is actively traded on Bitget Exchange, one of the world's largest cryptocurrency platforms with over 120 million registered users. Bitget offers spot trading for rXBI/USDT with highly competitive fees, as low as 0% for makers and 0.03% for takers. The platform supports more than 1300 cryptocurrencies including SPDR S&P Biotech ETF, maintains a protection fund exceeding $300 million, and provides 24/7 trading with deep liquidity. Bitget consistently ranks among the top exchanges by rXBI trading volume.

Sign up for a free Bitget account and start trading now!

Risk disclaimer

The above analysis is based on Bitget's real-time chart data and technical indicators, compiled and reviewed by the Bitget research team. It is for reference only and does not constitute investment advice. Cryptocurrency prices are highly volatile. Please make investment decisions based on your own risk tolerance.

Show more5m ago
GetAgent

GetAgent: Your AI for smarter trading decisions

What news is moving rXBI right now?
What could affect rXBI's future price?
What should I watch for rXBI this week?
Is market sentiment bullish or bearish for rXBI right now?
What key levels are traders watching for rXBI?
What upcoming events could move rXBI's price?
Is there strong buying or selling pressure on rXBI right now?
Will the Bhutan government’s $27.96 million BTC deposit into Binance trigger a sell-off and a market plunge?
UPBIT will delist the BONK trading pair in 2026—should you cut your losses and sell now?
Chainlink buys back $1.13 million worth of LINK and deposits it—if the buyback price is around $8, is it still worth chasing?
Ask anything on GetAgent
Buy/sell now

SPDR S&P Biotech ETF market info

Price performance (24h)
24h
24h low $154.9924h high $155.76
All-time high (ATH):
$174.86
Price change (24h):
-0.24%
Price change (7D):
+5.46%
Price change (1Y):
+72.48%

You can trade rXBI on Bitget

  • #
  • Pair
  • Type
  • Price
  • 24h volume
  • Action
  • 1
  • rXBI/USDT
  • Spot
  • 155.28
  • $82.55M
  • Trade
  • Hot stock assets trading on Bitget

    Spot stocks
    Stock perps
  • #
  • Pair
  • Type
  • Price
  • 24h volume
  • Action
  • 1
  • rEA/USDT
  • Spot
  • 209.91
  • $11.23B
  • Trade
  • 2
  • rSPY/USDT
  • Spot
  • 771.93
  • $3.41B
  • Trade
  • 3
  • rSPCX/USDT
  • Spot
  • 129.51
  • $3.05B
  • Trade
  • 4
  • rMU/USDT
  • Spot
  • 866.05
  • $2.31B
  • Trade
  • 5
  • rNVDA/USDT
  • Spot
  • 222.45
  • $2.02B
  • Trade
  • 6
  • rQQQ/USDT
  • Spot
  • 720.6
  • $1.63B
  • Trade
  • 7
  • rSNDK/USDT
  • Spot
  • 1231.02
  • $1.18B
  • Trade
  • 8
  • rAMD/USDT
  • Spot
  • 479.01
  • $1.07B
  • Trade
  • 9
  • rTSLA/USDT
  • Spot
  • 329.36
  • $907.86M
  • Trade
  • 10
  • rPLTR/USDT
  • Spot
  • 169.7
  • $707.58M
  • Trade
  • Detailed introduction to Bitget rToken (rXBI)

    Key features of Bitget rToken (rXBI)
    Asset attributeA tokenized stock pegged 1:1 to a real U.S. stock.
    IssuerReality (Bitget's licensed RWA protocol).
    DividendsDividends are automatically distributed to your account in USDT, with no manual action required.
    Fractional shareSupports fractional share trading, starting from as low as 1 USDT.
    Trading hoursSome rTokens offer native U.S. stock liquidity 24/5, while others support 24/7 trading.
    How to buyCan be purchased directly with USDT, USDC, or BTC, with no conversion required.
    Position usageCan be held as an investment position, and also used as combined margin for Bitget's unified trading account and USDT-M futures.

    In short, rXBI is a tokenized stock issued by licensed issuer Reality, pegged 1:1 to real SPDR S&P Biotech ETF stock. It supports 24/7 trading, fractional shares, and dividends, and can be used as margin for the platform's unified trading account and USDT-M futures.

    Buy rXBI

    How Bitget rToken (rXBI) works

    During U.S. market hours—including the regular session, pre-market, after-hours, and overnight sessions—spot orders for rXBI are routed directly through a broker to the Nasdaq or NYSE order book. Once the trade is executed on the U.S. stock market, the execution result is reflected in the on-exchange spot order record. Any order you place for rXBI while the U.S. market is open will also appear on the Nasdaq or NYSE order book. This means that during U.S. market hours, the trading price and liquidity of rXBI are exactly the same as those of the underlying stock. Orders for rXBI and their execution results are part of the U.S. stock market. There is no spread or so-called de-pegging, because rXBI trades are executed directly on the U.S. stock market itself. The execution price you see for rXBI is identical to the stock's price at that exact moment.

    This makes rXBI fundamentally different from traditional RWA tokens. The price of a traditional RWA asset is determined by on-chain liquidity and trading activity, whereas the price of rXBI is directly equivalent to the stock price—it does not rely on any other mechanism to peg the asset's price. In terms of trading outcomes, trading rXBI is no different from trading the stock directly.

    Buy rXBI with crypto assets on Bitget for the best stock trading experience

    Bitget's spot trading market has listed over 500 rTokens (including rXBI), offering native U.S. stock liquidity 24/5, with some trading pairs supporting 24/7 trading.

    Market liquidity: The only tokenized stock that aligns with the market price and liquidity of major U.S. stock exchanges such as Nasdaq and the NYSE.

    Maximum capital efficiency: rTokens can be used within the unified ecosystem for margin, Crypto Loans, Earn, and more, expanding the ways your assets can be used.

    More flexible trading: Supports stablecoin deposits, T+0 fund turnover, 24/5 trading, with some pairs supporting 24/7 trading.

    Fund security: The only RWA asset in the industry subject to daily third-party Proof of Reserves (PoR) audits, ensuring transparent asset reserves and protecting user funds.

    Dividend rights: Eligible dividends are paid out to users' accounts in USDT.

    Hold rXBI and enjoy corporate actions aligned with the underlying stock

    Corporate actions involving rXBI (including dividend payments, stock splits, and reverse splits) are handled in the same way that a traditional broker would handle a stock position.

    While holding rXBI, whenever SPDR S&P Biotech ETF stock pays a USD dividend, Reality automatically converts it into an equivalent amount of stablecoin (USDT) and distributes it 1:1 to the Bitget accounts of rXBI holders. As a result, holding rXBI entitles you to the same dividend rights as holding the actual stock, with the entire process handled automatically by the platform, requiring no manual action. It should be noted that dividends are subject to a flat 30% withholding tax applied by the U.S. to foreign investors. For users holding high-dividend assets (such as certain tech stocks or ETF-linked tokens), this means they can earn steady passive income on top of capital appreciation, further boosting the overall return on their holdings.

    The issuer of rXBI is based in El Salvador. Therefore, the withholding tax applicable to rXBI follows the U.S. withholding tax rules for El Salvador.

    Hold rXBI and enjoy the flexibility of a crypto asset

    Whether you're using a traditional broker or another platform, deposits and withdrawals are rarely a seamless experience. Traditional brokers may take time to process deposits. After a stock is sold, withdrawals typically take one to two days to process, and the funds may take even longer to arrive. Securities holdings also cannot be split, transferred, or reallocated. By contrast, rXBI offers far greater flexibility than traditional stocks.

    1. rXBI can be sold on the exchange, and the proceeds are immediately available for transfer, with no T+1 restriction.

    2. rXBI can be freely transferred, withdrawn, or moved between sub-accounts, offering great flexibility and convenience. rXBI is essentially a regular crypto asset, with no difference in use from Bitcoin.

    3. rXBI can be used directly as margin in a unified trading account to open futures positions. This allows users to participate in derivatives trading without selling their stock holdings, improving capital efficiency.

    4. rXBI can be used as collateral to borrow crypto assets such as USDT, USDC, and BTC on the platform for further trading or to purchase other rToken assets. This is similar to the margin lending services offered by traditional brokers and helps improve capital efficiency.

    Understanding the risks

    The advantage of rXBI is that its price is exactly the same as the underlying stock's while also benefiting from the stock's deep liquidity. Even for less actively traded stocks, institutions don't need to worry about unexpected liquidations caused by price spikes resulting from insufficient on-exchange liquidity, as can happen with traditional tokens.

    During weekends, when the U.S. stock market is closed, rXBI continues to function as collateral without interruption. Even though rXBI remains tradable over the weekend, its collateral value continues to be based on the last price before the U.S. market closes on Friday. This fixed index price is used for risk calculations, helping maintain a relatively stable collateral value and liquidation risk profile.

    Why choose Bitget rToken? What are the main advantages of Bitget rToken over traditional stock investing?

    AspectBitget rTokenTraditional brokers
    Simple account openingSign up with a mobile number or email address and complete identity verification—no proof of address requiredComplex account opening process (utility bills, etc.), requiring proof of address
    1:1 asset backingEach rToken corresponds to a real stock held in custody by a brokerDirect stock ownership
    Liquidity experienceSupports fractional-share trading from as little as 1 USDT, with 24/7 millisecond-level execution and seamless execution for large ordersSome brokers support fractional-share investing, but execution is limited by clearing firms, resulting in insufficient liquidity
    Transaction feesMaker fees as low as 0%; taker fees as low as 0.03%; no broker commissionsComplex fee structure: commissions ($0–$5 per trade), platform fees, exit fees, etc.
    Funding and currenciesBuy directly with USDT or BTC—no currency conversion requiredRequires fiat deposits, with exchange-rate losses on currency conversion
    Trading hours24/7 trading—buy or sell anytime, unrestricted by U.S. stock market hoursMostly limited to 9:30 AM–4:00 PM (EST) on trading days, with only some brokers supporting 24/5 trading
    Deposits and withdrawals24/7 near-instant deposits and withdrawals, with support for USDT, USDC, and other cryptocurrencies, plus direct wallet accessTraditional bank deposits, limited currency support, 1–2 working days, plus fees and exchange-rate losses
    Dividend distributionDividends are automatically paid to your wallet—no manual action requiredRequires manual reinvestment or waiting for a dividend check
    Regulatory complianceIssued by Reality Protocol (a licensed RWA issuer)SEC-registered brokers
    Asset security100% asset backing, plus a $300 million user protection fundInconsistent clearing rules; SIPC coverage capped at $500,000
    Buy rXBI now

    Where is the best place to buy crypto like SPDR S&P Biotech ETF (rXBI)?

    Trading statisticsBitget
    Spot trading fee (maker)As low as 0%
    Spot trading fee (taker)As low as 0.03% (0.024% with BGB)
    Futures trading fee (maker)As low as 0%
    Futures trading fee (taker)As low as 0.02%
    Max leverage (futures)125x
    Fiat trading fee0%
    Supported crypto assets1,300+
    Copy trading assets600+
    Protection fund value$300M+
    100% Proof of ReservesReserve ratio > 100% (verified by Merkle tree)
    Global users120M+
    Daily trading volume$20B+

    SPDR S&P Biotech ETF Price history (USD)

    The price of SPDR S&P Biotech ETF is +72.48% over the last year. The highest price of RXBI in USD in the last year was $165.71 and the lowest price of RXBI in USD in the last year was $89.73.
    TimePrice change (%)Price change (%)Lowest priceThe lowest price of {0} in the corresponding time period.Highest price Highest price
    24h-0.24%$154.99$155.76
    7d+5.46%$143.87$157.84
    30d+5.68%$143.87$157.84
    90d+13.59%$127.12$165.71
    1y+72.48%$89.73$165.71
    All-time+831.85%$15.67(--, Today)$174.86(--, Today)
    SPDR S&P Biotech ETF price historical data (all time)

    What is the highest price of SPDR S&P Biotech ETF?

    The rXBI all-time high (ATH) in USD was $174.86, recorded on . Compared to the SPDR S&P Biotech ETF ATH, the current SPDR S&P Biotech ETF price is down by 11.22%.

    What is the lowest price of SPDR S&P Biotech ETF?

    The rXBI all-time low (ATL) in USD was $15.67, recorded on . Compared to the SPDR S&P Biotech ETF ATL, the current SPDR S&P Biotech ETF price is up 890.68%.

    SPDR S&P Biotech ETF price prediction

    What will the price of rXBI be in 2027?

    In 2027, based on a +5% annual growth rate forecast, the price of SPDR S&P Biotech ETF(rXBI) is expected to reach $166.94; based on the predicted price for this year, the cumulative return on investment of investing and holding SPDR S&P Biotech ETF until the end of 2027 will reach +5%. For more details, check out the SPDR S&P Biotech ETF price predictions for 2026, 2027, 2030-2050.

    What will the price of rXBI be in 2030?

    In 2030, based on a +5% annual growth rate forecast, the price of SPDR S&P Biotech ETF(rXBI) is expected to reach $193.25; based on the predicted price for this year, the cumulative return on investment of investing and holding SPDR S&P Biotech ETF until the end of 2030 will reach 21.55%. For more details, check out the SPDR S&P Biotech ETF price predictions for 2026, 2027, 2030-2050.

    Hot promotions

    How to buy SPDR S&P Biotech ETF(rXBI)

    Create Your Free Bitget Account

    Create Your Free Bitget Account

    Sign up on Bitget with your email address/mobile phone number and create a strong password to secure your account.
    Verify Your Account

    Verify Your Account

    Verify your identity by entering your personal information and uploading a valid photo ID.
    Convert rXBI to USD

    Convert rXBI to USD

    Choose from cryptocurrencies to trade on Bitget.

    FAQ

    What is the current price of SPDR S&P Biotech ETF?

    The live price of SPDR S&P Biotech ETF is $155.25 per (rXBI/USD) with a current market cap of $0 USD. SPDR S&P Biotech ETF's value undergoes frequent fluctuations due to the continuous 24/7 activity in the crypto market. SPDR S&P Biotech ETF's current price in real-time and its historical data is available on Bitget.

    What is the 24 hour trading volume of SPDR S&P Biotech ETF?

    Over the last 24 hours, the trading volume of SPDR S&P Biotech ETF is --.

    What is the all-time high of SPDR S&P Biotech ETF?

    The all-time high of SPDR S&P Biotech ETF is $174.86. This all-time high is highest price for SPDR S&P Biotech ETF since it was launched.

    Can I buy SPDR S&P Biotech ETF on Bitget?

    Yes, SPDR S&P Biotech ETF is currently available on Bitget’s centralized exchange. For more detailed instructions, check out our helpful How to buy spdr-s-p-biotech-etf-tokenized-stock-reality guide.

    Can I get a steady income from investing in SPDR S&P Biotech ETF?

    Of course, Bitget provides a strategic trading platform, with intelligent trading bots to automate your trades and earn profits.

    Where can I buy SPDR S&P Biotech ETF with the lowest fee?

    Bitget offers industry-leading trading fees and depth to ensure profitable investments for traders. You can trade on the Bitget exchange.

    Where can I buy SPDR S&P Biotech ETF (rXBI)?

    Buy crypto on the Bitget app
    Sign up within minutes to purchase crypto via credit card or bank transfer.
    Download Bitget APP on Google PlayDownload Bitget APP on AppStore
    Trade on Bitget
    Deposit your cryptocurrencies to Bitget and enjoy high liquidity and low trading fees.

    Video section — quick verification, quick trading

    play cover
    How to complete identity verification on Bitget and protect yourself from fraud
    1. Log in to your Bitget account.
    2. If you're new to Bitget, watch our tutorial on how to create an account.
    3. Hover over your profile icon, click on “Unverified”, and hit “Verify”.
    4. Choose your issuing country or region and ID type, and follow the instructions.
    5. Select “Mobile Verification” or “PC” based on your preference.
    6. Enter your details, submit a copy of your ID, and take a selfie.
    7. Submit your application, and voila, you've completed identity verification!
    Buy SPDR S&P Biotech ETF for 1 USD
    A welcome pack worth 6200 USDT for new Bitget users!
    Buy SPDR S&P Biotech ETF now
    Cryptocurrency investments, including buying SPDR S&P Biotech ETF online via Bitget, are subject to market risk. Bitget provides easy and convenient ways for you to buy SPDR S&P Biotech ETF, and we try our best to fully inform our users about each cryptocurrency we offer on the exchange. However, we are not responsible for the results that may arise from your SPDR S&P Biotech ETF purchase. This page and any information included are not an endorsement of any particular cryptocurrency. Any price and other information on this page is collected from the public internet and can not be consider as an offer from Bitget.

    rXBI/USD price calculator

    rXBI
    USD
    1 rXBI = 155.25 USD. The current price of converting 1 SPDR S&P Biotech ETF (rXBI) to USD is 155.25. This rate is for reference only.
    Bitget offers the lowest transaction fees among all major trading platforms. The higher your VIP level, the more favorable the rates.

    rXBI resources

    SPDR S&P Biotech ETF rating
    4.5
    0 ratings
    Contracts:
    --
    Links:

    Prices of newly listed coins on Bitget

    share